Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse side-effects to biological agents.

W J Pichler1

  • 1Department for Rheumatology and Clinical Immunology/Allergology, Inselspital, University of Bern, Bern, Switzerland.

Allergy
|July 27, 2006
PubMed
Summary

Biological agents, used in cancer and inflammation therapy, can cause side effects. A new classification system categorizes these adverse events into five distinct types, aiding in better management and research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2013
Same author

In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2013
Same author

Intravenous immunoglobulin in urticaria.

Journal of investigational allergology & clinical immunology·2013
Same author

Allergy workup of severe cutaneous adverse drug reactions: a light at the end of the tunnel?

The British journal of dermatology·2013
Same author

Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA.

Allergy·2012
Same author

Etiology and pathogenesis of adverse drug reactions.

Chemical immunology and allergy·2012

Area of Science:

  • Immunology
  • Pharmacology
  • Oncology

Background:

  • Biological agents like cytokines, monoclonal antibodies, and fusion proteins are crucial in anti-inflammatory and tumor therapies.
  • While effective, these agents can induce a range of adverse side effects.
  • Existing classifications for drug side effects do not fully capture the unique nature of biological agent toxicities.

Purpose of the Study:

  • To propose a novel classification system for adverse side effects of biological agents.
  • To differentiate these side effects from those caused by conventional chemicals and drugs.
  • To facilitate better clinical management and research into biological agent toxicities.

Main Methods:

  • Development of a new classification framework based on the distinct characteristics of biological agents.
  • Categorization of adverse events into five specific types: Type alpha (high cytokine levels), Type beta (hypersensitivity), Type gamma (immune/cytokine imbalance), Type delta (cross-reactivity), and Type epsilon (non-immune system effects).

Main Results:

  • A novel five-type classification system for biological agent adverse side effects has been proposed.
  • Type alpha: Clinical reactions due to high cytokine levels.
  • Type beta: Hypersensitivity from immune reactions to the agent.
  • Type gamma: Immune or cytokine imbalance syndromes.
  • Type delta: Symptoms arising from cross-reactivity.
  • Type epsilon: Symptoms not directly impacting the immune system.

Conclusions:

  • The proposed classification provides a structured approach to understanding and managing biological agent side effects.
  • This system can aid in identifying individual and general risk factors for these adverse events.
  • It offers a foundation for directing future research in this specialized area of medicine.

Related Experiment Videos